Atlas Trials

Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

Clinical trial NCT02455479 · RECRUITING

Trial details

NCT number
NCT02455479
Sponsor
Weill Medical College of Cornell University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Cocaine Dependence
Start date
2012-06-26
Primary completion
2026-12-01
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.